A detailed history of B&L Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, B&L Asset Management LLC holds 4,931 shares of BMY stock, worth $230,820. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,931
Previous 4,696 5.0%
Holding current value
$230,820
Previous $217 Million 2.3%
% of portfolio
0.11%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

BUY
$43.31 - $48.98 $10,177 - $11,510
235 Added 5.0%
4,931 $222 Million
Q1 2025

May 14, 2025

BUY
$53.9 - $63.11 $8,085 - $9,466
150 Added 3.3%
4,696 $286 Million
Q4 2024

Feb 14, 2025

SELL
$51.92 - $59.94 $28,659 - $33,086
-552 Reduced 10.83%
4,546 $257 Million
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $202,186 - $263,821
5,098 New
5,098 $264 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track B&L Asset Management LLC Portfolio

Follow B&L Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B&L Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on B&L Asset Management LLC with notifications on news.